It's definitely something that needs to be considered.
First of all, it's natural that pharmaceutical companies may argue against pharmacare because they do make a lot of money from Canada. We pay far more for our medication than any other country that has a universal health care system. It's definitely to their advantage for us to continue like this because we pay more for medication than most other countries that have universal health care.
The argument around research has definitely also been looked at. We don't have any higher levels of research than other places that have a pharmacare program. There's not a clear link to show that if we switch to a pharmacare program we would have less research, because there's a great deal of research that happens in countries that have national pharmacare, or something similar, as compared with Canada. That argument that there's less research in places that have a national program hasn't really been shown to be true.